Breakthrough in Cancer Care: Multi4 Medical’s New Technology Cleared by FDA
Swedish MedTech company Multi4 Medical, chaired by renowned investor Erik Selin, has received FDA clearance for its patended technology for automated cancer treatment. The decision means that Multi4 is now approved for commercial sale in the U.S., the world’s largest and most competitive healthcare market.
This regulatory milestone validates Multi4’s innovative approach to cancer care, offering treatments that can be completed in just minutes – without the need for general anesthesia, hospital admission, or long waiting times. Patients can now receive treatment during a regular outpatient visit, significantly reducing both healthcare costs and patient burden.
